Pharma Focus Asia

Sonata Therapeutics and the Champalimaud Foundation Announce Joint Research Effort for SNT-3012 Targeting Pancreatic and Colorectal Cancers

Wednesday, March 06, 2024

Sonata Therapeutics, a biotechnology company specializing in the development of a novel category of treatments known as Network Medicines™, has announced a collaboration with the Champalimaud Foundation. This partnership aims to advance the development of Sonata's innovative Network Medicine, SNT-3012, for the treatment of pancreatic and colorectal cancers.

The collaboration brings together Sonata's expertise in Network Medicines with the Champalimaud Foundation's access to patient-derived samples and its scientific and clinical excellence. Together, they will conduct proof-of-concept studies to support the clinical development of SNT-3012.

Dr. Francesco Marincola, Chief Scientific Officer of Sonata Therapeutics, stated, "Network Medicines have the potential to address challenging diseases by coordinating the efforts of various cells within a disease network. We are excited to collaborate with the Champalimaud Foundation to further explore the potential of SNT-3012 in treating pancreatic and colorectal cancers."

The Immunotherapy team at the Champalimaud Foundation also expressed their commitment to advancing scientific discoveries from the lab to the clinic. They believe that Network Medicines have the potential to transform the standard of care for pancreatic and colorectal cancers and look forward to collaborating with Sonata to develop new treatment options.

Network Medicines represent a new approach to therapeutics, designed to reprogram diseased cells and coordinate the actions of different cell types within a network to resolve disease. SNT-3012, Sonata's preclinical Network Medicine, has shown promising results in preclinical studies for pancreatic and colorectal cancers, demonstrating significant tumor regression in various models.



magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024